Lakeside Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Lakeside Advisors's AMGN Position: Q2 2026 in Review
Lakeside Advisors increased its Amgen (AMGN) stake by 0.22% in Q2 2026, buying an estimated $1.03K and bringing the position to 1,346 shares worth $487K. The position accounts for 0.31% of the portfolio, ranked #50.
Lakeside Advisors first reported a position in AMGN in Q4 2021 and has held it in 19 quarters since. 3,163 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Lakeside Advisors held 1,346 shares of Amgen worth $487K as of Q2 2026.
- Lakeside Advisors bought 3 Amgen shares in Q2 2026, an estimated $1.03K.
- Amgen made up 0.31% of Lakeside Advisors's portfolio in Q2 2026, its #50 holding.
- Lakeside Advisors first reported a position in Amgen in Q4 2021 and has held it in 19 quarters since.
- 3,163 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Lakeside Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.